Article

The pros and cons of local resection of choroidal melanoma

Author(s):

Spanish investigators found that local resection may offer better visual results and eye sparing without compromising local tumor control and survival.

Choroidal tumor resection is an alternative to brachytherapy in selected cases,

Choroidal tumor resection is an alternative to brachytherapy in selected cases,

Resection of choroidal tumors is a treatment option but it is technically challenging and more challenging than removing tumors in the iris and ciliary body because the choroid is less accessible.

In a review of the literature on surgical procedures to remove choroidal tumors via endoresection (ab interno) or transscleral resection (ab externo), Spanish investigators found that local resection may offer better visual results and eye sparing without compromising local tumor control and survival, but there are come caveats attached,1 according to lead author Josep Maria Caminal, MD, from the Department of Ophthalmology, Ocular Oncology and Vitreoretinal Service, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain.

The investigators used the PubMed database of the U.S. National Library of Medicine and the Cochrane Central Register of Controlled Trials of the Cochrane Library to compare the 2 methods of choroidal tumor excision for visual outcomes, survival rates, and complications.

Twenty-five studies met the inclusion criteria; 12 studies described exoresection (6 retrospective studies and 6 comparative studies) and 13 described endoresection (11 retrospective and 2 comparative studies).

The investigators reported that both surgeries are indicated to remove large tumors with thicknesses exceeding 8 mm with small base diameters. In addition to eliminating the risk associated with radiotherapy, surgery provides clinicians the opportunity to obtain histopathologic and cytogenetic data from surgical specimens. However, both surgeries are challenging and carry the risk of severe early and late postoperative complications.

Caminal and colleagues provided several key points.

“Choroidal tumor resection is an alternative to brachytherapy in selected cases,” Caminal said. “The available data suggest that this approach may offer better visual results and eye sparing without compromising local tumor control and survival.”

Investigators also noted that sesection techniques for choroidal tumors are based on modern vitreoretinal surgical techniques, which allow for the treatment of more challenging cases.

The main limitations to surgical resection of these tumors are the risk of severe complications, which may include retinal detachment, proliferative vitreoretinopathy, severe intraoperative hemorrhage, air embolism, and local tumor recurrence at the resection edge.

Surgical resection of uveal melanomas should be limited to centers with substantial experience in the management of intraocular tumors,” investigators concluded.

Reference

Caminal JM, Lorenzo D, Gutierrez C, et al. Local resection in choroidal melanoma: a review. J Clin Med 2022;11:7156; https://doi.org/10.3390/jcm11237156

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
© 2025 MJH Life Sciences

All rights reserved.